These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8408455)

  • 1. In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus.
    Ohno Y; Aoki N; Nishimura A
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1072-7. PubMed ID: 8408455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals.
    Netea MG; Hancu N; Blok WL; Grigorescu-Sido P; Popa L; Popa V; van der Meer JW
    Cytokine; 1997 Apr; 9(4):284-7. PubMed ID: 9112337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased in vitro interleukin-12 production by peripheral blood in high-risk IDDM first degree relatives.
    Szelachowska M; Kretowski A; Kinalska I
    Horm Metab Res; 1997 Apr; 29(4):168-71. PubMed ID: 9178025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment.
    Desfaits AC; Serri O; Renier G
    Diabetes Care; 1998 Apr; 21(4):487-93. PubMed ID: 9571329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High glucose concentrations increase the tumor necrosis factor-alpha production capacity by human peripheral blood mononuclear cells.
    Hâncu N; Netea MG; Baciu I
    Rom J Physiol; 1998; 35(3-4):325-30. PubMed ID: 11061332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Case study of interleukin-1 beta, tumor necrosis factor alpha and interleukin-6 production peripheral blood monocytes in patients with diabetes mellitus complicated by pulmonary tuberculosis].
    Tsukaguchi K; Yoneda T; Yoshikawa M; Tokuyama T; Fu A; Tomoda K; Narita N; Enoki Y; Tsukaguchi M; Shirai F
    Kekkaku; 1992 Dec; 67(12):755-60. PubMed ID: 1294780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus.
    Pociot F; Mølvig J; Wogensen L; Worsaae H; Dalbøge H; Baek L; Nerup J
    Scand J Immunol; 1991 Jan; 33(1):37-49. PubMed ID: 1996407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocyte function in IDDM patients and healthy individuals.
    Mølvig J; Pociot F; Baek L; Worsaae H; Dall Wogensen L; Christensen P; Staub-Nielsen L; Mandrup-Poulsen T; Manogue K; Nerup J
    Scand J Immunol; 1990 Sep; 32(3):297-311. PubMed ID: 1698309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary supplementation with omega-3-polyunsaturated fatty acids decreases mononuclear cell proliferation and interleukin-1 beta content but not monokine secretion in healthy and insulin-dependent diabetic individuals.
    Mølvig J; Pociot F; Worsaae H; Wogensen LD; Baek L; Christensen P; Mandrup-Poulsen T; Andersen K; Madsen P; Dyerberg J
    Scand J Immunol; 1991 Oct; 34(4):399-410. PubMed ID: 1656517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells.
    Spatz M; Eibl N; Hink S; Wolf HM; Fischer GF; Mayr WR; Schernthaner G; Eibl MM
    Cell Immunol; 2003 Jan; 221(1):15-26. PubMed ID: 12742378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinamide inhibits enhanced in vitro production of interleukin-12 and tumour necrosis factor-alpha in peripheral whole blood of people at high risk of developing type 1 diabetes and people with newly diagnosed type 1 diabetes.
    Kretowski A; Myśliwiec J; Szelachowska M; Kinalski M; Kinalska I
    Diabetes Res Clin Pract; 2000 Feb; 47(2):81-6. PubMed ID: 10670906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of in vitro cytokine production by monocytes during sepsis.
    Munoz C; Carlet J; Fitting C; Misset B; Blériot JP; Cavaillon JM
    J Clin Invest; 1991 Nov; 88(5):1747-54. PubMed ID: 1939659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
    Matsumoto N; Aze Y; Akimoto A; Fujita T
    J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF alpha, IL-1 beta and IL-6 production by peripheral blood monocytes in patients with renal cell carcinoma.
    Ikemoto S; Sugimura K; Yoshida N; Wada S; Yamamoto K; Kishimoto T
    Anticancer Res; 2000; 20(1A):317-21. PubMed ID: 10769674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced interleukin-1beta, interleukin-6 and tumor necrosis factor-alpha production by LPS stimulated human monocytes isolated from HIV+ patients.
    Baqui AA; Jabra-Rizk MA; Kelley JI; Zhang M; Falkler WA; Meiller TF
    Immunopharmacol Immunotoxicol; 2000 Aug; 22(3):401-21. PubMed ID: 10946822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monokines and endothelial cell proliferation in patients with diabetes mellitus.
    Dosquet C; Wautier MP; Guillausseau PJ; Wautier JL
    Diabete Metab; 1994; 20(1):37-42. PubMed ID: 8056134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes. Quantitative differences at the polymorphic level.
    Santamaria P; Gehrz RC; Bryan MK; Barbosa JJ
    J Immunol; 1989 Aug; 143(3):913-22. PubMed ID: 2787351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children.
    Dogan Y; Akarsu S; Ustundag B; Yilmaz E; Gurgoze MK
    Mediators Inflamm; 2006; 2006(1):59206. PubMed ID: 16864906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus.
    Berman MA; Sandborg CI; Wang Z; Imfeld KL; Zaldivar F; Dadufalza V; Buckingham BA
    J Immunol; 1996 Nov; 157(10):4690-6. PubMed ID: 8906850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coxsackievirus B3-induced production of tumor necrosis factor-alpha, IL-1 beta, and IL-6 in human monocytes.
    Henke A; Mohr C; Sprenger H; Graebner C; Stelzner A; Nain M; Gemsa D
    J Immunol; 1992 Apr; 148(7):2270-7. PubMed ID: 1312105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.